Genome‐wide cfDNA testing of maternal blood-Reference-Cited by-同舟云学术

Genome‐wide cfDNA testing of maternal blood

Published:2020-01 Issue:1 Volume:55 Page:13-14
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound Obstet Gynecol

Author:

Jani J. C.¹,Gil M. M.²^ORCID,Benachi A.³,Prefumo F.⁴,Kagan K. O.⁵,Tabor A.⁶,Bilardo C. M.⁷,Di Renzo G. C.⁸,Nicolaides K. H.⁹

Affiliation:

1. Department of Obstetrics and GynecologyUniversity Hospital Brugmann, Université Libre de Bruxelles Brussels Belgium

2. Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de ArdozUniversidad Francisco de Vitoria Madrid Spain

3. Department of Obstetrics and Gynecology, Antoine‐Béclère Hospital, Assistance Publique‐Hôpitaux de Paris (AP‐HP)Université Paris‐Sud Clamart France

4. Division of Obstetrics and Gynecology, Department of Clinical and Experimental SciencesUniversity of Brescia Brescia Italy

5. Tuebingen University HospitalObstetrics and Gynaecology Tuebingen Germany

6. Center of Fetal Medicine, Department of ObstetricsCopenhagen University Hospital Rigshospitalet Copenhagen Denmark

7. Department of Obstetrics & GynaecologyAmsterdam University Medical Centers Amsterdam The Netherlands

8. Department of Obstetrics and Gynecology, Centre for Perinatal and Reproductive MedicineUniversity Hospital, University of Perugia Perugia Italy

9. Fetal Medicine Research InstituteKing's College Hospital London UK

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/uog.21945

Reference15 articles.

1. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta‐analysis

2. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis

3. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands

4. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA

5. Cell‐free DNA analysis in maternal blood: comparing genome‐wide versus targeted approach as a first‐line screening test;Wergifosse S;J Matern Fetal Neonatal Med,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal Screening of Chromosomal Anomalies Using Genome-Wide or Target Cell-Free DNA: Preferences and Satisfaction of Pregnant Women;Journal of Clinical Medicine;2024-08-19

2. Performance Evaluation of Noninvasive Prenatal Testing in Screening Chromosome Disorders: A Single-Center Observational Study of 15,304 Consecutive Cases in China;International Journal of Women's Health;2024-03

3. Noninvasive prenatal screening for fetal aneuploidies;Diagnostic Molecular Pathology;2024

4. Ersttrimester-Klinik zum Zeitpunkt 11–13+6 Schwangerschaftswochen: Screening, Risikoberechnung und Management;Springer Reference Medizin;2024

5. Ersttrimester-Klinik zum Zeitpunkt 11–13+6 Schwangerschaftswochen: Screening, Risikoberechnung und Management;Springer Reference Medizin;2024